Preferred Label : tezacaftor, ivacaftor drug combination;
MeSH synonym : tezacaftor and ivacaftor; tezacaftor; ivacaftor; tezacaftor - ivacaftor;
Origin ID : C000654124;
UMLS CUI : C4542171;
ATC code(s)
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
https://www.ema.europa.eu/en/medicines/human/EPAR/symkevi
2021
false
false
false
Netherlands
French
English
drug approval
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
tezacaftor, ivacaftor drug combination
tezacaftor
tezacaftor
ivacaftor
ivacaftor
administration, oral
ivacaftor and tezacaftor
Chloride Channel Agonists
Chloride Channel Agonists
cystic fibrosis
drug interactions
pregnancy
breast feeding
child
adolescent
adult
orphan drug production
drug monitoring
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
aged
drug evaluation, preclinical
aminophenols
indoles
quinolones
benzodioxoles
indoles
benzodioxoles
indoles
benzodioxoles
aminophenols
quinolones
aminophenols
quinolones
---
https://www.has-sante.fr/jcms/p_3282752/fr/symkevi-100-mg/150-mg-ivacaftor/-tezacaftor-mucoviscidose-6-ans
2021
false
false
false
France
evaluation of the transparency committee
aminophenols
drug combinations
indoles
quinolones
benzodioxoles
child
adolescent
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
cystic fibrosis
tezacaftor, ivacaftor drug combination
tezacaftor
ivacaftor
ivacaftor and tezacaftor
drug therapy, combination
treatment outcome
insurance, health, reimbursement
administration, oral
---
https://www.has-sante.fr/jcms/p_3289700/fr/symkevi-tezacaftor/ivacaftor-en-association-avec-kalydeco-ivacaftor-mucoviscidose-enfants-6-ans
2021
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
administration, oral
drug therapy, combination
tezacaftor, ivacaftor drug combination
ivacaftor
cystic fibrosis
cystic fibrosis
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
CFTR delta F508
---
https://www.has-sante.fr/jcms/p_3184439/fr/symkevi-/-kalydeco
2020
false
false
false
France
drug combinations
administration, oral
insurance, health, reimbursement
ivacaftor and tezacaftor
ivacaftor
cystic fibrosis
adolescent
Product containing only ivacaftor and tezacaftor in oral dose form (medicinal product
form)
tezacaftor
CFTR delta F508
treatment outcome
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
tezacaftor, ivacaftor drug combination
evaluation of the transparency committee
ivacaftor
aminophenols
quinolones
aminophenols
quinolones
indoles
benzodioxoles
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00402
2018
false
false
false
Canada
French
drug information
administration, oral
drug approval
canada
ivacaftor and tezacaftor
drug combinations
tezacaftor
tezacaftor
ivacaftor
ivacaftor
cystic fibrosis
adolescent
adult
cystic fibrosis
cystic fibrosis transmembrane conductance regulator
mutation
treatment outcome
indoles
benzodioxoles
indoles
benzodioxoles
aminophenols
quinolones
aminophenols
quinolones
tezacaftor, ivacaftor drug combination
---